New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
Central Railway Announces Major NI Blocks On Kalyan–Lonavala Section From Nov 26; Pune–Lonavala Suburban & Multiple Long-Distance Trains To Be Affected; Check Details
'Hamare Se Galti Hua': Kalyan's Ideal College Students Apologise, Touch Shivaji Statue's Feet For Offering Namaz On Campus | WATCH
Delhi CM Rekha Gupta Launches Drive To Distribute 10,000 Electric Heaters To Curb Pollution
IIT Madras, BHU Varanasi To Host Fourth Kashi Tamil Sangamam From December 2
